Skip to main content
# Title Department Research Year
41 Evaluation of the therapeutic potential of novel nanoparticle formulations of glutathione and virgin coconut oil in an experimental model of carbon tetrachloride-induced liver … Department of Pharmacology 2024
42 Sertaconazole-PLGA nanoparticles for management of ocular keratitis Department of Pharmaceutics 2024
43 Design, synthesis, and antiproliferative activity of new 1,2,3-Triazole/Quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
44 Nanostructured gold-embedded porous carbon black nanoceramic film coating on pencil graphite rods: An innovative disposable ultrasensitive sensor for monitoring dopamine Department of Pharmaceutical Analytical Chemistry 2024
45 A surfactant-based quasi-hydrophobic deep eutectic solvent for dispersive liquid-liquid microextraction of gliflozins from environmental water samples using UHPLC/fluorescence detection Department of Pharmaceutical Analytical Chemistry 2024
46 New diaryl-1,2,4-triazolo[3,4-a]pyrimidine hybrids as selective COX-2/sEH dual inhibitors with potent analgesic/anti-inflammatory and cardioprotective properties Department of Pharmaceutical Organic Chemistry 2024
47 Combining lavendustin C and 5-arylidenethiazolin-4-one-based pharmacophores toward multitarget anticancer hybrids Department of Pharmaceutical Organic Chemistry 2024
48 Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists Department of Pharmaceutical Organic Chemistry 2024
49 Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L. Department of Pharmacognosy 2024
50 Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024